{
    "root": "c06685ab-240e-4fe6-a382-cc20b74a67f0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Allopurinol",
    "value": "20250305",
    "ingredients": [
        {
            "name": "ALLOPURINOL",
            "code": "63CZ7GJN5I"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        }
    ],
    "indications": "allopurinol tablet indicated : \u2022 management adults signs symptoms primary secondary gout ( acute attacks , tophi , joint destruction , uric acid lithiasis , and/or nephropathy ) \u2022 management adult pediatric patients leukemia , lymphoma solid tumor malignancies receiving cancer therapy causes elevations serum urinary uric acid levels \u2022 management adult patients recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day male patients 750 mg/day female patients , despite lifestyle changes ( reduction dietary sodium , non-dairy animal protein , oxylate rich foods , refined sugars increases oral fluids fruits vegetables ) limitations allopurinol tablets recommended treatment asymptomatic hyperuricemia .",
    "contraindications": "\u2022 gout : prior initiating treatment assess serum uric acid level , complete blood count , chemistry panel , liver kidney function tests . prophylactic treatment gout flares recommended . ( 2.1 , 2.2 ) - patients normal kidney function : initial 100 mg orally daily . increase 100 mg weekly increments serum uric acid 6 mg/dl less reached ( maximum 800 mg daily ) . ( 2.3 ) - patients impaired kidney function : initial 50 mg orally daily . follow recommendations titration patients renal impairment target serum uric acid level reached . ( 2.6 ) - complete information full prescribing information ( fpi ) . \u2022 hyperuricemia associated cancer therapy : recommended : - adults : 300 mg 800 mg orally daily . - pediatric patients : 100 mg/m 2 orally every 8 hours 12 hours ( 10 mg/kg/day , maximum 800 mg/day ) - complete information fpi . ( 2.4 , 2.6 ) \u2022 recurrent calcium oxalate calculi : recommended initial patients normal kidney function 200 mg 300 mg orally daily . ( 2.5 ) \u2022 patients renal impairment : fpi modifications patients renal impairment . ( 2.6 )",
    "warningsAndPrecautions": "supplied allopurinol tablets usp , 100 mg white off-white , round , flat uncoated tablets debossed ' 1 ' either side breakline one side '209 ' side supplied follows : overbagged 10 tablets per bag , ndc 55154-2338-0 storage handling store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "allopurinol tablets contraindicated patients history hypersensitivity reaction allopurinol ingredients allopurinol tablets .",
    "indications_original": "Allopurinol tablet is indicated for:\n                  \n                     \n                        \u2022\u00a0 The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy)\n                     \n                        \u2022\u00a0 The management of adult and pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels\n                     \n                        \u2022\u00a0 The management of adult patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients, despite lifestyle changes (such as reduction of dietary sodium, non-dairy animal protein, oxylate rich foods, refined sugars and increases in oral fluids and fruits and vegetables)\n                  \n                  \n                     Limitations of Use\n                  \n                  Allopurinol tablets are not recommended for the treatment of asymptomatic hyperuricemia.",
    "contraindications_original": "\u2022 Gout : Prior to initiating treatment assess serum uric acid level, complete blood count, chemistry panel, liver and kidney function tests. Prophylactic treatment for gout flares is recommended. ( 2.1 , 2.2 ) -\u00a0\u00a0 Patients with normal kidney function: Initial dosage is 100 mg orally daily. Increase by 100 mg weekly increments until serum uric acid of 6 mg/dl or less is reached (maximum 800 mg daily). ( 2.3 ) -\u00a0\u00a0 Patients with impaired kidney function: The initial dosage is 50 mg orally daily. Follow recommendations for titration in patients with renal impairment until target serum uric acid level is reached. ( 2.6 ) -\u00a0\u00a0\u00a0See complete information in the Full Prescribing Information (FPI). \u2022 Hyperuricemia      Associated with Cancer Therapy : The recommended dosage is: -\u00a0\u00a0 Adults: 300 mg to 800 mg orally daily. -\u00a0\u00a0 Pediatric patients: 100 mg/m 2 orally every 8 hours to 12 hours (10 mg/kg/day, maximum 800 mg/day) -\u00a0\u00a0 See complete information in the FPI. ( 2.4 , 2.6 ) \u2022 Recurrent Calcium Oxalate Calculi : The recommended initial dosage in patients with normal kidney function is 200 mg to 300 mg orally daily. ( 2.5 ) \u2022 Dosage in Patients with Renal Impairment: See FPI for dosage modifications in patients with renal impairment. ( 2.6 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  Allopurinol Tablets USP, 100 mg are white to off-white, round, flat uncoated tablets debossed with '1' on either side of breakline on one side and '209' on other side and are supplied as follows:\n                  Overbagged with 10 tablets per bag, NDC 55154-2338-0\n                  \n                     Storage and Handling\n                  \n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Allopurinol tablets are contraindicated in patients with a history of hypersensitivity reaction to allopurinol or to any of the ingredients of allopurinol tablets."
}